| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/09/2004 | US6703486 Peripheral nervous system specific sodium channels |
| 03/09/2004 | US6703369 Lipase inhibiting compositions |
| 03/09/2004 | US6703238 Methods for expanding antigen-specific T cells |
| 03/09/2004 | US6703232 Contacting human embryo kidney 293 (hek 293) cells with at least two different reoviruses to infect; incubation to reassort; harvesting |
| 03/09/2004 | US6703052 Long chain monounsaturated alcohol mixtures |
| 03/09/2004 | US6703017 Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
| 03/09/2004 | US6703016 Apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines |
| 03/09/2004 | CA2138793C Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections |
| 03/04/2004 | WO2004018689A1 Anti-neoplastic viruses |
| 03/04/2004 | WO2004018683A1 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine |
| 03/04/2004 | WO2004018680A1 Method of screening tumor antigen |
| 03/04/2004 | WO2004018658A1 Human bone stem cells |
| 03/04/2004 | WO2004018654A2 Cell culture surface |
| 03/04/2004 | WO2004018652A2 Method for obtaining diploid, pluripotential stem cells and use thereof |
| 03/04/2004 | WO2004018002A2 Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells |
| 03/04/2004 | WO2004017984A1 Method for cancer therapy using herbal extracts |
| 03/04/2004 | WO2004017979A2 Medicament, food supplement, and fodder additive |
| 03/04/2004 | WO2004017978A1 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| 03/04/2004 | WO2004017946A1 Treating alzheimers using delipidated protein particles |
| 03/04/2004 | WO2004017916A2 Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
| 03/04/2004 | WO2004017895A2 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 03/04/2004 | WO2004017727A1 A method of treatment and prophylaxis |
| 03/04/2004 | WO2004001020A3 Methods and means to promote gut absorption |
| 03/04/2004 | WO2003105908A9 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 03/04/2004 | WO2003103720A3 Compositions and methods for the use of bcl-2 transfected neurons |
| 03/04/2004 | WO2003097871A8 Marker molecules associated with lung tumors |
| 03/04/2004 | WO2003097091A3 Glucan-based vaccines |
| 03/04/2004 | WO2003095630A3 Bioartificial skin comprising genetically modified fibroblasts |
| 03/04/2004 | WO2003083089A3 Tolerogenic antigen-presenting cells |
| 03/04/2004 | WO2003060082A3 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 03/04/2004 | WO2003059276A3 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 03/04/2004 | WO2003055980A3 Il-17 like molecules and uses thereof |
| 03/04/2004 | WO2003043574A3 Pharmaceutical compositions in particulate form |
| 03/04/2004 | WO2003039566A3 Methods of treatment in situ in the lungs of mammals |
| 03/04/2004 | WO2003019198A3 Methods relating to treatment of atherosclerosis |
| 03/04/2004 | WO2003019196A3 Diagnosis and treatment of atherosclerosis |
| 03/04/2004 | WO2003015759A3 Treatment of hyperproliferative conditions of body surfaces |
| 03/04/2004 | WO2002102971A3 Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance |
| 03/04/2004 | WO2002096263A3 Eb matrix production from fetal tissues and its use for tissue repair |
| 03/04/2004 | WO2002089675A9 Wound closure system and methods |
| 03/04/2004 | WO2002074946A3 Method for generating insulin-secreting cells suitable for transplantation |
| 03/04/2004 | WO2002020762A8 Tnf receptor-like molecules and uses thereof |
| 03/04/2004 | WO2002012502A9 Anti-tnf antibodies, compositions, methods and uses |
| 03/04/2004 | US20040045045 Animal model for toxicology and dose prediction |
| 03/04/2004 | US20040044408 Cell-culture and polymer constructs |
| 03/04/2004 | US20040044407 Heart valves obtained from fish eyes |
| 03/04/2004 | US20040044300 Method of replenishing cells damaged by treatment for cancer |
| 03/04/2004 | US20040044221 Anticancer ganets; drug resistance |
| 03/04/2004 | US20040043963 Complex of chitosan, conjugated linoleic acid, vitamin a and cyclodextrin |
| 03/04/2004 | US20040043936 Antiproliferative and antiviral proteins and peptides |
| 03/04/2004 | US20040043484 Hematopoietic differentiation of human embryonic stem cells |
| 03/04/2004 | US20040043483 Culture comprising nervous system tissue for use in preventing and/or minimizing transplant rejection and autoimmune diseases |
| 03/04/2004 | US20040043464 Comprises nucleotide sequences coding oligosaccharide biosynthetic enzymes for use as tools in genetic engineering and detection of neisseria infections |
| 03/04/2004 | US20040043441 Methods of quantifying methotrexate metabolites |
| 03/04/2004 | US20040043411 DSP-11 dual-specificity phosphatase |
| 03/04/2004 | US20040043380 A T cell line carrying a reporter gene that contains an long terminal repeat (LTR) sequence of Human Immunodeficiency Virus (HIV); for use in an efficient screening method for efficiently finding out a medicine such as an anti-HIV agents |
| 03/04/2004 | US20040043090 Process for the preparation of an extract with Carotenoids, UV absorption, antibacterial and pH indicating properties from a deep-sea bacterium |
| 03/04/2004 | US20040043084 Incubation extractin presence of aerobic metabolizing microorganisms; cosmetics, drugs |
| 03/04/2004 | US20040043080 Pharmaceutical compositions and health foods for preventing and treating male sterility comprising oyster extract and ginseng extract |
| 03/04/2004 | US20040043056 Diet composition comprising raw foods and dietary fibers |
| 03/04/2004 | US20040043012 Lactic acid bacteria cultures that inhibit food-borne pathogens |
| 03/04/2004 | US20040043011 Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa |
| 03/04/2004 | US20040043009 Method of repairing primate mammalian tissue |
| 03/04/2004 | US20040043008 Dissociation muscle tissues; culturing; accumulation |
| 03/04/2004 | US20040043007 Transfection system |
| 03/04/2004 | US20040043006 Tissue regenerative composition |
| 03/04/2004 | US20040043003 Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions |
| 03/04/2004 | DE10261126A1 Lagerungsstabile, flüssige Fibrinogen-Formulierung Storage stable liquid fibrinogen formulation |
| 03/04/2004 | DE10238169A1 Verfahren zur vereinfachten Herstellung einer Zusammensetzung mit hohem Avarolgehalt mit verbesserter Wirkung sowie dessen Verwendung zur Behandlung proliferativer Funktionsstörungen oder zur Herstellung von reinem Avarol und Avaron hieraus A process for the simplified preparation of a composition with a high Avarolgehalt having improved activity and the use thereof for treating proliferative disorders or for preparing pure avarol and avarone thereof |
| 03/04/2004 | CA2535952A1 Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells |
| 03/04/2004 | CA2504019A1 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| 03/04/2004 | CA2496831A1 Treating alzheimers using delipidated protein particles |
| 03/04/2004 | CA2496485A1 Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis |
| 03/04/2004 | CA2495535A1 Cell culture surface |
| 03/03/2004 | EP1394551A2 Integrin as a predictor of endometriosis |
| 03/03/2004 | EP1393741A1 Storage-stable, liquid fibrinogen-formulation |
| 03/03/2004 | EP1393737A1 Pharmaceutical compositions and health foods for preventing and treating male sterility comprising oyster extract and ginseng extract |
| 03/03/2004 | EP1393071A2 Assay for predicting cell activity |
| 03/03/2004 | EP1393067A1 Encapsulated cell indicator system |
| 03/03/2004 | EP1393066A2 Insulin producing cells derived from human embryonic stem cells |
| 03/03/2004 | EP1392862A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 03/03/2004 | EP1392819A2 Keratinocytes obtained from embryonic stem cells of mammals |
| 03/03/2004 | EP1392818A1 Chimeric immunoreceptor useful in treating human cancers |
| 03/03/2004 | EP1392816A1 Production of bioavailable folic acid |
| 03/03/2004 | EP1392723A2 Medane genes and proteins |
| 03/03/2004 | EP1392623A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms |
| 03/03/2004 | EP1392375A2 Composition and use of substances for stabilising amino acids containing sulphur |
| 03/03/2004 | EP1392354A2 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds |
| 03/03/2004 | EP1392333A2 Manipulation of arterial-venous identity |
| 03/03/2004 | EP1392202A1 Submucosal xenografts |
| 03/03/2004 | EP1149167B1 Viral vaccine |
| 03/03/2004 | EP1119252A4 Use of melanin for inhibition of angiogenesis and macular degeneration |
| 03/03/2004 | EP1047437A4 Sea cucumber carotenoid lipid fraction products and methods of use |
| 03/03/2004 | EP1015017B1 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 03/03/2004 | EP0866726B1 Pulmonary administration of dry powder alpha 1-antitrypsin |
| 03/03/2004 | EP0733103B1 Generation of high titers of recombinant aav vectors |
| 03/03/2004 | EP0719150B1 Cellular vaccine and its use for the treatment of solid tumor malignancies |
| 03/03/2004 | EP0633929B1 METHOD FOR $i(IN VITRO) PROLIFERATION OF DENDRITIC CELL PRECURSORS AND THEIR USE TO PRODUCE IMMUNOGENS |
| 03/03/2004 | CN1479788A Lactic acid bacteria capable of reducing indvidual's tendency to develop allergic reactions |
| 03/03/2004 | CN1479638A Improvement of graft acceptance through manipulation of thymic regeneration |